Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma

被引：0
|
作者：
Zannoni, Gian Franco
Chiarello, Gaia
Petrillo, Marco
Improta, Giuseppina
Rossi, Esther D.
Fadda, Guido
Fraggetta, Filippo
机构：
[1] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy
[2] IRCCS CROB Hosp, Potenza, Italy
[3] Org Osped Cannizzaro, Catania, Italy
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1267
引用
收藏
页码：316A / 317A
页数：2
相关论文
共 50 条
  • [31] EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
    Bujko, Mateusz
    Kober, Paulina
    Tysarowski, Andrzej
    Matyja, Ewa
    Mandat, Tomasz
    Bonicki, Wieslaw
    Siedlecki, Janusz Aleksander
    ONCOLOGY LETTERS, 2014, 7 (06) : 2019 - 2022
  • [32] Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
    Takahashi N.
    Yamada Y.
    Taniguchi H.
    Fukahori M.
    Sasaki Y.
    Shoji H.
    Honma Y.
    Iwasa S.
    Takashima A.
    Kato K.
    Hamaguchi T.
    Shimada Y.
    BMC Research Notes, 7 (1)
  • [33] Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA
    Hoshino, Hitomi
    Inoue, Daisuke
    Shinagawa, Akiko
    Yoshida, Hisato
    Shigeto, Shohei
    Matsuda, Kazuyuki
    Akama, Tomoya O.
    Yoshida, Yoshio
    Kobayashi, Motohiro
    HUMAN CELL, 2024, 37 (04) : 1184 - 1193
  • [34] KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers Diagnostic and Therapeutic Implications
    Balschun, Katharina
    Haag, Jochen
    Wenke, Ann-Kathrin
    von Schoenfels, Witigo
    Schwarz, Nicolas T.
    Roecken, Christoph
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (04) : 436 - 445
  • [35] PIK3CA Gene Mutations and Amplifications in Chinese Patients With Ovarian Clear Cell Carcinoma
    Jiang, Gaofeng
    Huang, Zhixiong
    Zhang, Shuangling
    Wang, Lin
    CANCER INVESTIGATION, 2013, 31 (10) : 639 - 644
  • [36] Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
    Murakami, Kosuke
    Kanto, Akiko
    Sakai, Kazuko
    Miyagawa, Chiho
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Kotani, Yasushi
    Nishio, Kazuto
    Matsumura, Noriomi
    MODERN PATHOLOGY, 2021, 34 (11) : 2071 - 2079
  • [37] EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer
    Martin, Vittoria
    Zanellato, Elena
    Franzetti-Pellanda, Alessandra
    Molinari, Francesca
    Movilia, Alessandra
    Paganotti, Alessia
    Deantonio, Letizia
    De Dosso, Sara
    Assi, Agnese
    Crippa, Stefano
    Boldorini, Renzo
    Mazzucchelli, Luca
    Saletti, Piercarlo
    Frattini, Milo
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (04) : 513 - 521
  • [38] Mutational profile of KRAS, NRAS, BRAF, PIK3CA, and AKT1 genes in colorectal cancer patients in a tertiary care hospital, Dhaka
    Chowdhury, Sharmin
    Ara, Sheikh Joly Ferdous
    Mili, Shirazum Monira
    Momotaz, Tahani
    Molla, Md Maruf Ahmed
    Anwar, Shaheda
    Abu Saleh, Ahmed
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2022, 5
  • [39] Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study
    Wojas-Krawczyk, Kamila
    Kalinka-Warzocha, Ewa
    Reszka, Katarzyna
    Nicos, Marcin
    Szumilo, Justyna
    Mandziuk, Slawomir
    Szczepaniak, Katarzyna
    Kupnicka, Dorota
    Lewandowski, Remigiusz
    Milanowski, Janusz
    Krawczyk, Pawel
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (01): : 67 - 73
  • [40] Molecular Profiling of KRAS, BRAF, and PIK3CA Mutation in Correlation with MSI Status in Indian Colorectal Carcinoma Patients
    Das, B.
    Ahmad, F.
    Bisht, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06) : 826 - 826
12345